Gilles de la Tourette syndrome (GTS) is a potentially debilitating neuropsychiatric disorder defined by the presence of both vocal and motor tics. Despite evidence that this and a related phenotypic spectrum, including chronic tics (CT) and Obsessive Compulsive Disorder (OCD), are genetically mediated, no gene involved in disease etiology has been identified. Chromosomal abnormalities have long been proposed to play a causative role in isolated cases of GTS spectrum phenomena, but confirmation of this hypothesis has yet to be forthcoming. A comprehensive characterization of this genomic interval led to the identification of two transcripts, neither of which was found to be structurally disrupted. Analysis of the epigenetic characteristics of the region demonstrated a significant increase in replication asynchrony in the patient compared to controls, with the inverted chromosome showing delayed replication timing across at least a 500-kb interval.
Organism species: Homo sapiens (Human)
CATALOG NO. | PRODUCT NAME | APPLICATIONS | |
Proteins | n/a | Recombinant Gilles De La Tourette Syndrome Chromosome Region, Candidate 1 (GTSCR1) | Recombinant Protein Customized Service Offer |
Antibodies | n/a | Monoclonal Antibody to Gilles De La Tourette Syndrome Chromosome Region, Candidate 1 (GTSCR1) | Monoclonal Antibody Customized Service Offer |
n/a | Polyclonal Antibody to Gilles De La Tourette Syndrome Chromosome Region, Candidate 1 (GTSCR1) | Polyclonal Antibody Customized Service Offer | |
Assay Kits | n/a | CLIA Kit for Gilles De La Tourette Syndrome Chromosome Region, Candidate 1 (GTSCR1) | CLIA Kit Customized Service Offer |
n/a | ELISA Kit for Gilles De La Tourette Syndrome Chromosome Region, Candidate 1 (GTSCR1) | ELISA Kit Customized Service Offer |
- "Epigenetic abnormalities associated with a chromosome 18(q21-q22) inversion and a Gilles de la Tourette syndrome phenotype."Proc. Natl. Acad. Sci. U.S.A. 100:4684-4689(2003) [PubMed] [Europe PMC] [Abstract]
- "DNA sequence and analysis of human chromosome 18." Nature 437:551-555(2005) [PubMed] [Europe PMC] [Abstract]